# HOPE to Reduce Tumour Recurrence After LT In Patients With HCC

> **NCT05876052** · NA · UNKNOWN · sponsor: **University of Bologna** · enrollment: 192 (estimated)

## Conditions studied

- Liver Cancer
- Tumor Recurrence
- Hepatocellular Carcinoma
- Liver Transplantation
- Ex-vivo Hypothermic Perfusion

## Interventions

- **DEVICE:** Hypothermic oxygenated Perfusion - HOPE

## Key facts

- **NCT ID:** NCT05876052
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05
- **Primary completion:** 2024-05
- **Final completion:** 2025-05
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2023-05-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05876052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05876052, "HOPE to Reduce Tumour Recurrence After LT In Patients With HCC". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05876052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*